Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
0.2710
Dollar change
-0.0189
Percentage change
-6.52
%
Index- P/E- EPS (ttm)-0.11 Insider Own2.92% Shs Outstand217.26M Perf Week1.80%
Market Cap58.88M Forward P/E- EPS next Y-0.10 Insider Trans0.00% Shs Float210.93M Perf Month-0.73%
Income-22.94M PEG- EPS next Q-0.03 Inst Own11.92% Short Float0.63% Perf Quarter11.52%
Sales1.10M P/S53.52 EPS this Y-4.55% Inst Trans3.06% Short Ratio1.04 Perf Half Y105.77%
Book/sh0.09 P/B3.06 EPS next Y13.04% ROA-31.77% Short Interest1.32M Perf Year-37.41%
Cash/sh0.06 P/C4.26 EPS next 5Y- ROE-82.11% 52W Range0.11 - 0.89 Perf YTD25.35%
Dividend Est.- P/FCF- EPS past 5Y7.12% ROI-103.62% 52W High-69.55% Beta1.54
Dividend TTM- Quick Ratio5.93 Sales past 5Y2359.11% Gross Margin14.14% 52W Low145.69% ATR (14)0.03
Dividend Ex-Date- Current Ratio5.93 EPS Y/Y TTM11.88% Oper. Margin-1081.92% RSI (14)51.66 Volatility20.72% 13.07%
Employees32 Debt/Eq0.18 Sales Y/Y TTM-65.62% Profit Margin-2093.25% Recom1.00 Target Price0.65
Option/ShortNo / Yes LT Debt/Eq0.15 EPS Q/Q-45.83% Payout- Rel Volume0.96 Prev Close0.29
Sales Surprise- EPS Surprise33.33% Sales Q/Q-100.00% EarningsMar 27 AMC Avg Volume1.27M Price0.27
SMA20-0.94% SMA5013.06% SMA20010.45% Trades Volume1,208,391 Change-6.52%
Date Action Analyst Rating Change Price Target Change
May-11-21Downgrade Piper Sandler Overweight → Neutral
Aug-26-20Resumed Piper Sandler Overweight
Jan-27-20Initiated Piper Sandler Overweight $3
Jan-24-20Initiated SunTrust Buy
Jan-23-20Initiated SunTrust Buy
Jan-09-20Initiated Aegis Capital Buy $3.50
Jun-26-19Initiated H.C. Wainwright Buy $4
Today 06:46AM
Mar-27-24 04:05PM
Mar-25-24 08:00AM
Mar-22-24 12:37PM
09:15AM
06:30AM Loading…
06:30AM
Feb-26-24 08:00AM
Feb-20-24 07:30AM
Jan-03-24 07:00AM
Dec-27-23 07:30AM
Dec-21-23 07:30AM
Nov-10-23 01:15PM
Nov-09-23 08:52AM
08:41AM
Nov-08-23 06:42PM
04:05PM Loading…
04:05PM
Nov-07-23 07:30AM
Nov-01-23 07:00AM
Oct-11-23 07:30AM
Sep-28-23 07:00AM
Sep-27-23 07:00AM
Sep-22-23 05:25PM
Sep-21-23 09:35AM
Sep-06-23 07:00AM
Aug-22-23 07:30AM
Aug-10-23 11:05AM
Aug-09-23 04:05PM
Aug-02-23 07:00AM
Jul-26-23 08:00AM
May-11-23 01:44PM
07:30AM Loading…
07:30AM
06:30AM
May-10-23 05:15PM
04:05PM
May-03-23 07:00AM
May-02-23 02:16PM
Apr-27-23 06:36PM
Apr-18-23 08:00AM
Mar-18-23 03:12AM
Mar-16-23 05:42AM
Mar-15-23 04:05PM
Mar-08-23 07:00AM
Mar-02-23 07:00AM
Jan-30-23 04:01PM
Jan-23-23 07:00AM
Jan-20-23 10:49AM
Jan-12-23 07:00AM
Nov-02-22 05:55PM
04:02PM
Oct-27-22 07:00AM
Oct-24-22 05:30AM
Oct-21-22 07:48AM
07:00AM
Oct-19-22 07:10AM
Oct-12-22 07:00AM
Sep-21-22 07:00AM
Sep-07-22 07:00AM
Aug-30-22 09:35AM
Aug-11-22 07:45AM
06:30AM
Aug-01-22 07:00AM
Jul-28-22 04:15PM
Jul-25-22 06:30AM
Jun-20-22 09:22AM
May-31-22 07:00AM
May-12-22 07:45AM
06:30AM
May-05-22 07:00AM
May-03-22 07:00AM
Apr-12-22 02:51PM
Apr-11-22 11:52AM
07:00AM
Apr-06-22 07:00AM
Mar-22-22 07:00AM
Mar-16-22 10:00AM
Mar-08-22 06:30AM
Feb-28-22 07:00AM
Jan-25-22 06:30AM
Jan-18-22 07:00AM
Dec-16-21 06:30AM
Dec-06-21 06:30AM
Nov-18-21 07:00AM
Nov-08-21 07:55AM
06:35AM
Nov-02-21 07:00AM
Oct-29-21 03:00PM
Oct-25-21 07:00AM
Oct-21-21 07:00AM
Oct-05-21 12:00PM
Sep-23-21 07:00AM
Sep-20-21 07:00AM
Sep-14-21 12:04PM
07:13AM
07:00AM
Sep-13-21 08:36AM
06:00AM
Aug-16-21 07:00AM
Aug-10-21 07:45AM
06:31AM
Aug-03-21 07:30AM
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.